Selective lead compounds against kinetoplastid tubulin.
Kinetoplastid parasites are responsible for the potentially fatal diseases leishmaniasis, African sleeping sickness and Chagas disease. The current treatments for these diseases are far from ideal and new compounds are needed as antiparasitic drug candidates. Tubulin is the accepted target for treatments against cancer and helminths, suggesting that kinetoplastid tubulin is also a suitable target for antiprotozoal compounds. Selective lead compounds against kinetoplastid tubulin have been identified that could represent a starting point for the development of new drug candidates against these parasites.
Morgan
R E
RE
Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, 500 West 12th Avenue, Columbus, Ohio 43210, USA.
Werbovetz
K A
KA
D000818:Animals; D018105:DNA, Kinetoplast / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism; D014344:Trypanocidal Agents / Q000494:pharmacology*; D014351:Trypanosomatina / Q000187:drug effects*; D014404:Tubulin / Q000737:chemistry / Q000187:drug effects / Q000378:metabolism*
D018105:DNA, Kinetoplast; D014344:Trypanocidal Agents; D014404:Tubulin